/
PETS
$1.76+$0.06 (+3.41%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$37.6M
21M shares
52-week range
$1.57 – $4.10
8% from low
Sector
RETAIL-DRUG STORES AND PROPRIETARY STORES
Exchange
NASDAQ
CS
Borrow rate
0.36%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-32.18
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $283.4M | $284.1M | $303.6M | $273.4M | $256.6M | $274.1M | $227.0M | $179.0M |
| Cost of revenue | $188.1M | $202.9M | $219.3M | $198.1M | $185.8M | $196.4M | $157.8M | $138.2M |
| Gross profit | $95.3M | $81.2M | $84.3M | $75.3M | $71.0M | $77.7M | $69.1M | $40.8M |
| Gross margin | 33.6% | 28.6% | 27.8% | 27.6% | 27.7% | 28.4% | 30.5% | 22.8% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $46.2M | $31.0M | $30.5M | $25.7M | $6.6M | −$7.0M | −$1.5M | −$31.4M |
| EBITDA | $51.3M | $36.1M | $33.0M | $29.8M | $11.0M | $783.0K | $6.7M | −$22.0M |
| Net income | $37.7M | $25.9M | $23.9M | $21.1M | $5.1M | −$7.5M | −$6.3M | −$57.3M |
| Net margin | 13.3% | 9.1% | 7.9% | 7.7% | 2.0% | -2.7% | -2.8% | -32.0% |
| EPS (diluted) | 1.84 | 1.29 | 1.52 | 1.04 | 0.25 | -0.37 | -0.30 | -2.74 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $180M | $0.07 | $0.07–$0.07 | 1 |
| 2028 | $184M | $0.09 | $0.09–$0.09 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.18
Price
$1.76
Implied downside
-90%
Peer comparison
PetMed Express, Inc.
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
www.petmeds.com- Employees
- 189
- IPO / List date
- Sep 17, 1997
- HQ
- DELRAY BEACH, FL
Held by traders on TradeandTell
No one on the platform currently holds PETS.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,186,369 | $2.7M |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 17.05% ($0.30/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2023-08-11 | $0.3000 | 2023-08-18 |
Recent trades on TradeandTell
No one on the platform has traded PETS yet.
